{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T09:45:31Z","timestamp":1785923131198,"version":"3.56.0"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Mechanical circulatory support (MCS) devices represent a major advance in the management of advanced heart failure and cardiogenic shock. Despite significant improvements in device technology and patient outcomes, infection remains the most common adverse event, affecting approximately 37% of patients and contributing substantially to morbidity and mortality. This state-of-the-art, multidisciplinary review comprehensively examines infections in patients who require durable or temporary mechanical circulatory support devices with contributions from experts in advanced heart failure, cardiovascular imaging, infectious diseases, cardiothoracic surgery, and pharmacology. We review the underlying pathophysiology of MCS-related infections, examine current preventative, diagnostic and management strategies, outline established best practices, discuss emerging technologies and therapies, and identify existing knowledge gaps and areas for future investigation.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1910836","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:56:40Z","timestamp":1785920200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Infections in mechanical circulatory support"],"prefix":"10.3389","volume":"13","author":[{"given":"Pallabi","family":"Shrestha","sequence":"first","affiliation":[{"name":"Division of Cardiology, University of Arizona","place":["Tucson, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitoj","family":"Singh","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Arizona","place":["Tucson, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Alexander","family":"Perry","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Arizona","place":["Tucson"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Acharya","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Arizona","place":["Tucson, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ijaz","family":"Pervez","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Arizona","place":["Tucson, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica DeAngelo","family":"De La Rosa","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Pharmacy, Banner University Medical Center","place":["Tucson, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline R.","family":"Finger","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Pharmacy, Banner University Medical Center","place":["Tucson, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinobu","family":"Kazui","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, Banner University Medical Center","place":["Tucson, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Acharya","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Arizona","place":["Tucson, AZ, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.healun.2024.03.004","article-title":"The International Society for Heart and Lung Transplantation (ISHLT): 2024 infection definitions for durable and acute mechanical circulatory support devices","volume":"43","author":"Aslam","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"B2","first-page":"201","article-title":"Infectious complications associated with ventricular assist device support","volume":"33","author":"McBride","year":"1987","journal-title":"ASAIO Trans"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1056\/NEJMoa1602954","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers","year":"2017","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJMoa1900486","article-title":"A fully magnetically levitated left ventricular assist device - final report","volume":"380","author":"Mehra","year":"2019","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.healun.2019.01.007","article-title":"Epidemiology of infection in mechanical circulatory support: a global analysis from the ISHLT mechanically assisted circulatory support registry","volume":"38","author":"Hannan","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.athoracsur.2025.10.005","article-title":"The Society of Thoracic Surgeons Intermacs 2025 annual report: focus on outcomes in older adults","volume":"121","author":"Nayak","year":"2026","journal-title":"Ann Thorac Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"ofaa124","DOI":"10.1093\/ofid\/ofaa124","article-title":"In full flow: left ventricular assist device infections in the modern era","volume":"7","author":"Zinoviev","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.healun.2018.04.004","article-title":"Interagency registry for mechanically assisted circulatory support report on the total artificial heart","volume":"37","author":"Arab\u00eda","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e13552","DOI":"10.1111\/ctr.13552","article-title":"Ventricular assist device-related infections and solid organ transplantation-guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Koval","year":"2019","journal-title":"Clin Transplant"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.healun.2017.06.007","article-title":"An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection","volume":"36","author":"Kusne","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jtcvs.2019.02.088","article-title":"Biofilm formation and migration on ventricular assist device drivelines","volume":"159","author":"Qu","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.healun.2020.07.015","article-title":"Characterization of infected, explanted ventricular assist device drivelines: the role of biofilms and microgaps in the driveline tunnel","volume":"39","author":"Qu","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1086\/505453","article-title":"Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis","volume":"26","author":"Kallen","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/QCO.0b013e32833ae214","article-title":"Decolonization therapy in infection control","volume":"23","author":"Hebert","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jtcvs.2016.01.060","article-title":"Prevention and management of sternal wound infections","volume":"152","author":"Lazar","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.athoracsur.2005.06.034","article-title":"The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration","volume":"81","author":"Edwards","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"ofad465","DOI":"10.1093\/ofid\/ofad465","article-title":"Left ventricular assist device: review of antimicrobial prophylaxis strategies and incidence of infections at a tertiary care center 12-year experience","volume":"10","author":"Mendoza","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1086\/646690","article-title":"Antimicrobial prophylaxis in surgery: mechanisms, misconceptions, and mischief","volume":"14","author":"Ehrenkranz","year":"1993","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/ejhf.2327","article-title":"Guidance on the management of left ventricular assist device (LVAD) supported patients for the non-LVAD specialist healthcare provider: executive summary","volume":"23","author":"Ben Gal","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B23","year":"2025"},{"key":"B24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.healun.2014.11.021","article-title":"Reduction in driveline infection rates: results from the HeartMate II multicenter driveline silicone skin interface (SSI) registry","volume":"34","author":"Dean","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"B25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MAT.0000000000000121","article-title":"Modified HeartMate II driveline externalization technique significantly decreases incidence of infection and improves long-term survival","volume":"60","author":"Singh","year":"2014","journal-title":"ASAIO J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"S1703","DOI":"10.21037\/jtd.2018.03.127","article-title":"Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices-5-year follow-up","volume":"10","author":"Wert","year":"2018","journal-title":"J Thorac Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/aor.14440","article-title":"Prophylactic negative pressure wound therapy is not effective for preventing driveline infection following left ventricular assist device implantation","volume":"47","author":"Tsuji","year":"2023","journal-title":"Artif Organs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.healun.2025.02.1139","article-title":"Negative pressure wound therapy for prevention of left ventricular assist device drivelin-specific infection","volume":"44","author":"Cangut","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/ejcts\/ezab195","article-title":"Driveline exit-site care protocols in patients with left ventricular assist devices: a systematic review","volume":"60","author":"Koken","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.healun.2015.06.010","article-title":"Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections","volume":"35","author":"Cagliostro","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"B31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.cardfail.2018.07.464","article-title":"Substantial reduction in driveline infection rates with the modification of driveline dressing protocol","volume":"24","author":"Lander","year":"2018","journal-title":"J Card Fail"},{"key":"B32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jcrc.2019.12.014","article-title":"Prevention and early treatment of driveline infections in ventricular assist device patients - the DESTINE staging proposal and the first standard of care protocol","volume":"56","author":"Bernhardt","year":"2020","journal-title":"J Crit Care"},{"key":"B33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.healun.2025.07.024","article-title":"Heterogeneity in HeartMate 3 implanting center infection management reveals opportunities for quality improvement and best practice initiatives during left ventricular assist device support","volume":"45","author":"Cowger","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"B34","doi-asserted-by":"publisher","first-page":"S459","DOI":"10.1016\/j.healun.2021.01.1275","article-title":"Change in caregiver increases risk for driveline infection","volume":"40","author":"Johnson","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cardfail.2020.05.018","article-title":"Left ventricular assist device caregiver experiences and health outcomes: a systematic review of qualitative and quantitative studies","volume":"26","author":"Streur","year":"2020","journal-title":"J Card Fail"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.healun.2008.07.021","article-title":"INTERMACS database for durable devices for circulatory support: first annual report","volume":"27","author":"Kirklin","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"B37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.healun.2011.01.717","article-title":"Working formulation for the standardization of definitions of infections in patients using ventricular assist devices","volume":"30","author":"Hannan","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"B38","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/cid\/ciw698","article-title":"Prevention and infection management in mechanical circulatory support device recipients","volume":"64","author":"Kusne","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/2156-7514.192835","article-title":"The role of computed tomography in predicting left ventricular assist device infectious complications","volume":"6","author":"Gomez","year":"2016","journal-title":"J Clin Imaging Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10140-025-02363-0","article-title":"Identifying key CT features and clinical variables for predicting operative management of left ventricular assist device (LVAD) driveline infections","volume":"32","author":"Mokkarala","year":"2025","journal-title":"Emerg Radiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jcmg.2019.04.024","article-title":"Diagnostic accuracy of FDG PET\/CT in suspected LVAD infections: a case series, systematic review, and meta-analysis","volume":"13","author":"Tam","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"B43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00259-020-04930-8","article-title":"The value of (18)F-FDG PET\/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and meta-analysis","volume":"48","author":"ten Hove","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B44","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2967\/jnumed.119.237628","article-title":"(18)F-FDG PET\/CT in left-ventricular assist device infection: initial results supporting the usefulness of image-guided therapy","volume":"61","author":"Sommerlath Sohns","year":"2020","journal-title":"J Nucl Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jcmg.2018.01.024","article-title":"FDG PET\/CT for early detection and localization of left ventricular assist device infection: impact on patient management and outcome","volume":"12","author":"Kim","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"B46","doi-asserted-by":"publisher","first-page":"18552","DOI":"10.1038\/s41598-023-45110-6","article-title":"Interplay between driveline infection, vessel wall inflammation, cerebrovascular events and mortality in patients with left ventricular assist device","volume":"13","author":"Hupe","year":"2023","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.healun.2023.11.002","article-title":"(18)F-FDG PET\/CT in left ventricular assist device infections: in-depth characterization and clinical implications","volume":"43","author":"Devesa","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.2967\/jnumed.125.270252","article-title":"Characterization of left ventricular assist device-specific infection by whole-body parametric PET imaging","volume":"66","author":"Derlin","year":"2025","journal-title":"J Nucl Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12350-018-1323-7","article-title":"Infections in patients using ventricular-assist devices: comparison of the diagnostic performance of (18)F-FDG PET\/CT scan and leucocyte-labeled scintigraphy","volume":"26","author":"de Vaugelade","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/aor.12254","article-title":"Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices","volume":"38","author":"Jennings","year":"2014","journal-title":"Artif Organs"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e13686","DOI":"10.1111\/tid.13686","article-title":"The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: a retrospective cohort from a tertiary care center","volume":"23","author":"Hamad","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5301\/ijao.5000285","article-title":"Dosing of vancomycin in patients with continuous-flow left ventricular assist devices: a clinical pharmacokinetic analysis","volume":"37","author":"Jennings","year":"2014","journal-title":"Int J Artif Organs"},{"key":"B53","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13019-021-01589-6","article-title":"Prevalence and management of driveline infections in mechanical circulatory support - a single center analysis","volume":"16","author":"Juraszek","year":"2021","journal-title":"J Cardiothorac Surg"},{"key":"B54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10047-020-01245-1","article-title":"Complex HeartWare left ventricular assist device infection treated with pump exchange: clinical alert for the driveline location","volume":"24","author":"Domae","year":"2021","journal-title":"J Artif Organs"},{"key":"B55","doi-asserted-by":"publisher","first-page":"233","DOI":"10.21037\/acs-2020-cfmcs-26","article-title":"Continuous-flow left ventricular assist device systems infections: current outcomes and management strategies","volume":"10","author":"Aburjania","year":"2021","journal-title":"Ann Cardiothorac Surg"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.athoracsur.2015.04.047","article-title":"Outcomes of heart transplant after left ventricular assist device specific and related infection","volume":"100","author":"Tong","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/aor.14721","article-title":"Absorbable antibiotic beads for treatment of LVAD driveline infections","volume":"48","author":"Wadiwala","year":"2024","journal-title":"Artif Organs"},{"key":"B58","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/01.mat.0000204760.48157.cc","article-title":"Case series: clinical management of persistent mechanical assist device driveline drainage using vacuum-assisted closure therapy","volume":"52","author":"Baradarian","year":"2006","journal-title":"ASAIO J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1177\/03913988211047250","article-title":"Treatment of HeartMate III-LVAD driveline infection by negative pressure wound therapy: result of our case series","volume":"44","author":"Cikirikcioglu","year":"2021","journal-title":"Int J Artif Organs"},{"key":"B60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1089\/wound.2018.0832","article-title":"Instillation negative pressure wound therapy: a role for infected LVAD salvage","volume":"8","author":"Hodson","year":"2019","journal-title":"Adv Wound Care (New Rochelle)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"S490","DOI":"10.1016\/j.healun.2020.01.065","article-title":"Driveline rerouting and incision & drainage for the management of chronic driveline infection in LVAD recipients","volume":"39","author":"Chauhan","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"B62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/jcdd12060211","article-title":"Driveline relocation and vacuum-assisted closure for ventricular assist device driveline infections","volume":"12","author":"Saricaoglu","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/jocs.12860","article-title":"Surgical management of driveline infections in patients with left ventricular assist devices","volume":"31","author":"Pieri","year":"2016","journal-title":"J Card Surg"},{"key":"B64","doi-asserted-by":"publisher","first-page":"S598","DOI":"10.1016\/j.healun.2024.02.910","article-title":"Omental wrapping for refractory driveline infection after heartmate 3 implantation","volume":"43","author":"Vinogradsky","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"B65","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ccl.2011.08.004","article-title":"Left ventricular assist device driveline infections","volume":"29","author":"Pereda","year":"2011","journal-title":"Cardiol Clin"},{"key":"B66","doi-asserted-by":"publisher","first-page":"S963","DOI":"10.21037\/jtd.2018.11.122","article-title":"Left ventricular assist devices exchange: why, when and how to do it\u2014experience from experts","volume":"11","author":"Schmack","year":"2019","journal-title":"J Thorac Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/aor.13378","article-title":"Device exchange versus nonexchange modalities in left ventricular assist device-specific infections: a systematic review and meta-analysis","volume":"43","author":"Bauer","year":"2019","journal-title":"Artif Organs"},{"key":"B68","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.healun.2024.11.032","article-title":"Pump exchange for major device related infection in patients receiving a durable left ventricular assist device","volume":"44","author":"Persaud","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"B69","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.healun.2025.10.014","article-title":"Impact of HeartMate 3 left ventricular assist device infection on outcomes following heart transplant","volume":"45","author":"Rushakoff","year":"2026","journal-title":"J Heart Lung Transplant"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e13692","DOI":"10.1111\/ctr.13692","article-title":"Outcomes of patients with infection related to a ventricular assist device after heart transplantation","volume":"33","author":"Moayedi","year":"2019","journal-title":"Clin Transplant"},{"key":"B71","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/MAT.0000000000000921","article-title":"The impact of left ventricular assist device infections on postcardiac transplant outcomes: a systematic review and meta-analysis","volume":"65","author":"Chahal","year":"2019","journal-title":"ASAIO J"},{"key":"B72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12028-018-0662-1","article-title":"Stroke risk following infection in patients with continuous-flow left ventricular assist device","volume":"31","author":"Cho","year":"2019","journal-title":"Neurocrit Care"},{"key":"B73","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jtcvs.2021.10.056","article-title":"Mortality following durable left ventricular assist device implantation by timing and type of first infection","volume":"166","author":"Zhou","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B74","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1540-8191.2010.01074.x","article-title":"Transcutaneous energy transmission for mechanical circulatory support systems: history, current status, and future prospects","volume":"25","author":"Slaughter","year":"2010","journal-title":"J Card Surg"},{"key":"B75","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/01.mat.0000943580.83459.85","article-title":"Wireless transcutaneous energy transfer and control system for powering a fully-implanted left-ventricular assist system","volume":"69","author":"Stein","year":"2023","journal-title":"ASAIO Journal"},{"key":"B76","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.healun.2019.01.1316","article-title":"First human use of a wireless coplanar energy transfer coupled with a continuous-flow left ventricular assist device","volume":"38","author":"Pya","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"B77","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/QCO.0000000000000999","article-title":"Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection\/acute bacterial skin and skin structure infection - issues and therapeutic options","volume":"37","author":"Eckmann","year":"2024","journal-title":"Curr Opin Infect Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/jcdd9110405","article-title":"New wound management of driveline infections with cold atmospheric plasma","volume":"9","author":"Kremer","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"21391","DOI":"10.1021\/acsomega.3c02239","article-title":"Advances in nanotechnology for biofilm inhibition","volume":"8","author":"Kumar","year":"2023","journal-title":"ACS Omega"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1028086","DOI":"10.3389\/fmicb.2022.1028086","article-title":"Nanotechnology in combating biofilm: a smart and promising therapeutic strategy","volume":"13","author":"Mohanta","year":"2022","journal-title":"Front Microbiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"ofaf158","DOI":"10.1093\/ofid\/ofaf158","article-title":"Targeting chronic biofilm infections with patient-derived phages: an in vitro and ex vivo proof-of-concept study in patients with left ventricular assist devices","volume":"12","author":"Pitton","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e0027225","DOI":"10.1128\/jcm.00272-25","article-title":"In vitro activity of antibiotic monotherapy and combination therapy with bacteriophages against Staphylococcus aureus LVAD-driveline infections","volume":"63","author":"Molendijk","year":"2025","journal-title":"J Clin Microbiol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/v15051210","article-title":"Successful bacteriophage-antibiotic combination therapy against multidrug-resistant Pseudomonas aeruginosa left ventricular assist device driveline infection","volume":"15","author":"Racenis","year":"2023","journal-title":"Viruses"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.028","article-title":"The International Society for Heart and Lung Transplantation\/Heart Failure Society of America guideline on acute mechanical circulatory support","volume":"42","author":"Bernhardt","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIR.0000000000001076","article-title":"Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association","volume":"146","author":"Geller","year":"2022","journal-title":"Circulation"},{"key":"B86","doi-asserted-by":"publisher","first-page":"37","DOI":"10.17925\/HI.2022.16.1.37","article-title":"A comprehensive review of mechanical circulatory support devices","volume":"16","author":"Atti","year":"2022","journal-title":"Heart Int"},{"key":"B87","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13054-024-04946-8","article-title":"Incidence, risk factors and outcomes of nosocomial infection in adult patients supported by extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"28","author":"Ait Hssain","year":"2024","journal-title":"Crit Care"},{"key":"B88","doi-asserted-by":"publisher","first-page":"100145","DOI":"10.1016\/j.ahjo.2022.100145","article-title":"Clinical profile and in-hospital outcome of patients supported by intra-aortic balloon pump in the clinical setting of cardiogenic shock","volume":"17","author":"Corsini","year":"2022","journal-title":"Am Heart J Plus"},{"key":"B89","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1017\/ice.2023.225","article-title":"Bloodstream infections in prolonged use of axillary-placed, intra-aortic balloon-pump support: a single-center study","volume":"45","author":"Dreucean","year":"2024","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jjcc.2024.09.009","article-title":"Clinical characteristics and short-term outcomes in patients with cardiogenic shock undergoing mechanical circulatory support escalation from intra-aortic balloon pump to impella: from the J-PVAD registry","volume":"85","author":"Yokoi","year":"2025","journal-title":"J Cardiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.jcin.2022.07.017","article-title":"Characteristics and impact of bloodstream infections in cardiogenic shock patients on temporary mechanical circulatory support","volume":"15","author":"Nair","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","article-title":"Microaxial flow pump or standard care in infarct-related cardiogenic shock","volume":"390","author":"M\u00f8ller","year":"2024","journal-title":"N Engl J Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.recesp.2020.11.011","article-title":"Infectious complications associated with short-term mechanical circulatory support in urgent heart transplant candidates","volume":"75","author":"Solla-Buceta","year":"2022","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"B95","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cardfail.2025.03.008","article-title":"Outcomes of surgically implanted impella microaxial flow pumps in heart failure-related cardiogenic shock","volume":"32","author":"Abraham","year":"2026","journal-title":"J Card Fail"},{"key":"B96","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/cid\/ciae120","article-title":"Nosocomial infections in adults receiving extracorporeal membrane oxygenation: a review for infectious diseases clinicians","volume":"79","author":"Marcus","year":"2024","journal-title":"Clin Infect Dis"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/cid\/cis783","article-title":"Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation","volume":"55","author":"Schmidt","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B98","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3346\/jkms.2017.32.4.593","article-title":"Nosocomial infection in adult patients undergoing veno-arterial extracorporeal membrane oxygenation","volume":"32","author":"Kim","year":"2017","journal-title":"J Korean Med Sci"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/microorganisms11041079","article-title":"Nosocomial infections in adult patients supported by extracorporeal membrane oxygenation in a cardiac intensive care unit","volume":"11","author":"Mornese Pinna","year":"2023","journal-title":"Microorganisms"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e0194976","DOI":"10.1371\/journal.pone.0194976","article-title":"Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: epidemiology and risk factors of treatment failure","volume":"13","author":"Bougl\u00e9","year":"2018","journal-title":"PLoS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e0308078","DOI":"10.1371\/journal.pone.0308078","article-title":"Risk factors for nosocomial infection in patients undergoing extracorporeal membrane oxygenation support treatment: a systematic review and meta-analysis","volume":"19","author":"Lv","year":"2024","journal-title":"PLoS One"},{"key":"B102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S2213-2600(22)00353-8","article-title":"Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study","volume":"11","author":"Martucci","year":"2023","journal-title":"Lancet Respir Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.amjmed.2013.09.017","article-title":"Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review","volume":"127","author":"Salpeter","year":"2014","journal-title":"Am J Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"101319","DOI":"10.1016\/j.accpm.2023.101319","article-title":"Infection in ECMO patients: changes in epidemiology, diagnosis and prevention","volume":"43","author":"Pena-Lopez","year":"2024","journal-title":"Anaesth Crit Care Pain Med"},{"key":"B105","year":"2012"},{"key":"B106","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13054-017-1644-y","article-title":"Medicating patients during extracorporeal membrane oxygenation: the evidence is building","volume":"21","author":"Dzierba","year":"2017","journal-title":"Crit Care"},{"key":"B107","doi-asserted-by":"publisher","first-page":"S629","DOI":"10.21037\/jtd.2017.09.154","article-title":"Optimising drug dosing in patients receiving extracorporeal membrane oxygenation","volume":"10","author":"Cheng","year":"2018","journal-title":"J Thorac Dis"},{"key":"B108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijantimicag.2017.02.025","article-title":"Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention","volume":"50","author":"Biffi","year":"2017","journal-title":"Int J Antimicrob Agents"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1910836\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:56:42Z","timestamp":1785920202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1910836\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":108,"alternative-id":["10.3389\/fcvm.2026.1910836"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1910836","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1910836"}}